WallStreetZen

NASDAQ: MRNA
Moderna Inc Stock Forecast, Predictions & Price Target

Analyst price target for MRNA

Based on 11 analysts offering 12 month price targets for Moderna Inc.
Min Forecast
$80.00-77.38%
Avg Forecast
$187.36-47.01%
Max Forecast
$250.00-29.3%

Should I buy or sell MRNA stock?

Based on 13 analysts offering ratings for Moderna Inc.
Buy
Strong Buy
4 analysts 30.77%
Buy
1 analysts 7.69%
Hold
6 analysts 46.15%
Sell
2 analysts 15.38%
Strong Sell
0 analysts 0%

MRNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Argus Research
Top 12%
89
Strong BuyMaintains$230.00-34.95%2021-06-24
Chardan Capital
Top 9%
92
Strong BuyMaintains$188.00-46.83%2021-05-07
Goldman Sachs
Top 10%
91
Strong BuyMaintains$228.00-35.52%2021-05-07
Piper Sandler
Top 20%
81
Strong BuyReiterates$234.00-33.82%2021-04-15
Oppenheimer
Bottom 18%
18
BuyMaintains$206.00-41.74%2021-02-01
Jefferies
Top 10%
91
HoldMaintains$250.00-29.30%2021-07-15
Anonymous
Morgan Stanley
HoldMaintains$190.00-46.27%2021-05-07
Morgan Stanley
Top 17%
84
HoldMaintains$201.00-43.16%2021-02-26
Wells Fargo
Top 33%
68
HoldMaintains$145.00-58.99%2021-02-01
Needham
Top 23%
78
HoldDowngradesN/AN/A2020-12-09

1 of 2

Forecast return on equity

Is MRNA forecast to generate an efficient return?
Company
-18.47%
Industry
9.04%
Market
59.33%
MRNA's Return on Equity is forecast to be low in 3 years (-18.47%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRNA forecast to generate an efficient return on assets?
Company
-5.58%
Industry
4.24%
Market
15.31%
MRNA is forecast to generate lower Return on Assets (-5.58%) than the US Biotechnology industry average (4.24%)
Forecast

MRNA earnings per share forecast

What is MRNA's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$25.60+1,665.74%
Avg 2 year Forecast
$17.70+1,120.69%
Avg 3 year Forecast
$7.42+411.86%
MRNA's earnings are forecast to grow at an exceptional rate of 77.07% per year
Forecast

MRNA revenue forecast

What is MRNA's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$18.4B+573.78%
Avg 2 year Forecast
$15.8B+476.7%
Avg 3 year Forecast
$8.8B+223.82%
MRNA's revenue is forecast to grow at an exceptional rate of 53.49% per year
Forecast

MRNA earnings growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
77.07%
Industry
38.19%
Market
18.21%
MRNA's earnings are forecast to grow faster (77.07% per year) than the US Biotechnology industry average (38.19%)
Forecast
MRNA's earnings are forecast to grow faster (77.07% per year) than the US market average (18.21%)
Forecast
MRNA's earnings are forecast to grow faster (77.07% per year) than the risk-free savings rate (1.2%)
Forecast

MRNA revenue growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
53.49%
Industry
50.82%
Market
13.5%
MRNA's revenues are forecast to grow faster (53.49% per year) than the US Biotechnology industry average (50.82%)
Forecast
MRNA's revenues are forecast to grow faster (53.49% per year) than the US market average (13.5%)
Forecast

Moderna Stock Forecast FAQ

Is Moderna Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: MRNA) stock is to Buy MRNA stock.

Out of 13 analysts, 4 (30.77%) are recommending MRNA as a Strong Buy, 1 (7.69%) are recommending MRNA as a Buy, 6 (46.15%) are recommending MRNA as a Hold, 2 (15.38%) are recommending MRNA as a Sell, and 0 (0%) are recommending MRNA as a Strong Sell.

What is MRNA's earnings growth forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's forecast annual earnings growth rate of 77.07% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 38.19%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.21%.

Moderna's earnings in 2021 is $598,166,000.On average, 9 Wall Street analysts forecast MRNA's earnings for 2021 to be $10,280,436,440, with the lowest MRNA earnings forecast at $6,970,522,417, and the highest MRNA earnings forecast at $12,800,705,913. On average, 9 Wall Street analysts forecast MRNA's earnings for 2022 to be $7,107,041,865, with the lowest MRNA earnings forecast at $3,192,145,923, and the highest MRNA earnings forecast at $10,238,958,620.

In 2023, MRNA is forecast to generate $2,980,139,250 in earnings, with the lowest earnings forecast at $-1,826,951,440 and the highest earnings forecast at $6,400,352,957.

What is MRNA's revenue growth forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's forecast annual revenue growth rate of 53.49% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.82%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 13.5%.

Moderna's revenue in 2021 is $2,732,006,000.On average, 8 Wall Street analysts forecast MRNA's revenue for 2021 to be $7,391,256,083,243, with the lowest MRNA revenue forecast at $5,423,801,236,311, and the highest MRNA revenue forecast at $9,064,108,385,275. On average, 8 Wall Street analysts forecast MRNA's revenue for 2022 to be $6,326,267,867,367, with the lowest MRNA revenue forecast at $4,473,581,708,365, and the highest MRNA revenue forecast at $9,010,082,821,266.

In 2023, MRNA is forecast to generate $3,552,198,300,113 in revenue, with the lowest revenue forecast at $1,601,292,822,532 and the highest revenue forecast at $5,087,987,485,259.

What is MRNA's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: MRNA) forecast ROA is -5.58%, which is lower than the forecast US Biotechnology industry average of 4.24%.

What is MRNA's Price Target?

According to 11 Wall Street analysts that have issued a 1 year MRNA price target, the average MRNA price target is $187.36, with the highest MRNA stock price forecast at $250.00 and the lowest MRNA stock price forecast at $80.00.

On average, Wall Street analysts predict that Moderna's share price could stay at $187.36 by Jul 15, 2022. The average Moderna stock price prediction forecasts a potential downside of N/A from the current MRNA share price of $353.60.

What is MRNA's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's current Earnings Per Share (EPS) is $1.45. On average, analysts forecast that MRNA's EPS will be $25.60 for 2021, with the lowest EPS forecast at $17.36, and the highest EPS forecast at $31.88. On average, analysts forecast that MRNA's EPS will be $17.70 for 2022, with the lowest EPS forecast at $7.95, and the highest EPS forecast at $25.50. In 2023, MRNA's EPS is forecast to hit $7.42 (min: $-4.55, max: $15.94).

What is MRNA's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: MRNA) forecast ROE is -18.47%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.